Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Institute of Biomaterials and Biomedical Engineering, University of Toronto, Ontario M5R 1M1, Canada.
Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Institute of Biomaterials and Biomedical Engineering, University of Toronto, Ontario M5R 1M1, Canada; Graduate Department of Pharmaceutical Science, Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada.
Acta Biomater. 2019 Apr 15;89:279-288. doi: 10.1016/j.actbio.2019.03.014. Epub 2019 Mar 7.
The synthesis of microspheres for tissue regeneration requires good control over the particle size and size distribution. This is particularly important when considering the immune response that may be triggered by the presence of particles in tissue. This report outlines the design of an injectable microsphere system using a low-inflammatory, degradable-polar-hydrophobic-ionic polyurethane, termed D-PHI, and investigates the system's performance in vitro and in vivo. Crosslinked polyurethane microspheres were prepared via a rapid and controlled process based on membrane emulsion and subsequent photopolymerization. The fabrication process efficiently generated microspheres with a narrow size distribution (12 ± 2 μm, PDI = 0.03). The D-PHI microspheres exhibited a slow and controlled degradation and a high capacity for water uptake. Water within the particles existed primarily within the pores of the particles and to a lesser degree within the polymer matrix itself. D-PHI microspheres supported human endothelial and fibroblast cell growth, and they maintained human blood-derived monocytes in a low-inflammatory state. Sub-acute toxicity was assessed for the particles after being administered via intramuscular injection in the gastrocnemius muscle of rats. Cellular infiltration and vascularization into the tissue region where the particles were deposited were observed along with an absence of a fibrous capsule around the particles. The microspheres did not cause elevated human monocyte induced inflammatory character, and supported tissue integration without a prolonged inflammatory response in the rat muscle. These injectable, degradable and low-inflammatory microspheres provide an attractive system for potential drug delivery and tissue regeneration applications in future studies. STATEMENT OF SIGNIFICANCE: Biodegradable, synthetic polymers are attractive candidates for generating tailored drug delivery vehicles and tissue scaffolds owing to their diverse chemical and physical properties that can be customised for delivering defined macromolecules at specific sites in the body. The past two decades have yielded interesting work exploring the fabrication of polymer microspheres with a narrow size distribution. However, the markedly low number of synthetic polymer chemistries currently used for microsphere production exhibit elevated proinflammatory character, both acute and chronic. Furthermore, a limited number of studies have explored the biocompatibility and immune response of polymeric microspheres with human primary cells and in vivo. In the current study, a method was conceived for efficiently generating low-activating polyurethane microspheres with respect to in vitro monocytes and in vivo macrophages. The biodegradable polyurethane, which contained multiple chemistry function and which has previously demonstrated anti-inflammatory properties in film and mm scale scaffold form, was selected as the base material. In this work we undertook the use of a room temperature membrane emulsification photopolymerization approach to avoid the need for high temperature cures and the use of solvents. The response of immune cells to the microspheres was studied with human primary cells and in the rat gastrocnemius muscle. The present work reveals important progress in the design of microspheres, with well-characterized low monocyte-activating properties and the translational advantages of a synthetic polyurethane which could be investigated in future studies for potential macromolecule delivery and tissue regeneration applications.
用于组织再生的微球合成需要很好地控制粒径和粒径分布。当考虑到组织中颗粒可能引发的免疫反应时,这一点尤为重要。本报告概述了使用低炎症、可降解极性疏水性离子型聚氨酯(称为 D-PHI)设计可注射微球系统的情况,并研究了该系统的体外和体内性能。交联聚氨酯微球通过基于膜乳液和随后的光聚合的快速和受控过程制备。该制造工艺有效地生成了具有窄粒径分布(12±2μm,PDI=0.03)的微球。D-PHI 微球表现出缓慢且受控的降解和高吸水性。颗粒内的水主要存在于颗粒的孔内,在聚合物基质本身内的程度较小。D-PHI 微球支持人内皮和成纤维细胞的生长,并使人类血液来源的单核细胞保持低炎症状态。在大鼠的比目鱼肌中通过肌肉内注射给药后,评估了颗粒的亚急性毒性。观察到颗粒沉积部位的组织中细胞浸润和血管生成,以及颗粒周围没有纤维囊。微球不会引起人单核细胞诱导的炎症特征升高,并支持组织整合,而不会在大鼠肌肉中引起长期炎症反应。这些可注射、可降解和低炎症的微球为未来的研究提供了一种有吸引力的用于潜在药物输送和组织再生应用的系统。 意义声明:可生物降解的合成聚合物因其可定制的化学和物理性质而成为生成定制药物输送载体和组织支架的有吸引力的候选物,这些性质可用于在体内特定部位递送达特定的大分子。过去二十年的研究工作探讨了具有窄粒径分布的聚合物微球的制造方法。然而,目前用于微球生产的合成聚合物化学物质数量明显较少,具有明显的促炎特性,无论是急性还是慢性。此外,很少有研究探讨了具有人类原代细胞和体内的聚合物微球的生物相容性和免疫反应。在本研究中,我们设计了一种方法,可有效地生成具有低激活体外单核细胞和体内巨噬细胞的低激活聚氨酯微球。选择具有多种化学功能的可生物降解的聚氨酯作为基础材料,该材料先前在薄膜和毫米级支架形式中表现出抗炎特性。在这项工作中,我们采用了室温膜乳化光聚合方法来避免需要高温固化和使用溶剂。使用人类原代细胞和大鼠比目鱼肌研究了免疫细胞对微球的反应。本工作在微球设计方面取得了重要进展,具有良好表征的低单核细胞激活特性,以及具有转化优势的合成聚氨酯,这可能在未来的研究中用于潜在的大分子输送和组织再生应用。